|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 471/14 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 495/04 | (2006.01) | ||
| C07D 519/00 | (2006.01) | ||
| A61K 31/4985 | (2006.01) | ||
| C07D 487/14 | (2006.01) | ||
| A61K 31/381 | (2006.01) | ||
| A61K 31/4353 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3002284 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15188086.1 |
| Date of filing the European patent application | 2012-11-02 | |
| (97) | Date of publication of the European application | 2016-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation | 2019-08-12 |
| (30) | Number | Date | Country code |
| 201161555393 P | 2011-11-03 | US |
| (72) |
Crawford, James John, US
Ortwine, Daniel Fred, US
Wei, BinQing, US
Young, Wendy B., US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Heteroarilo piridono ir aza-piridono junginiai, kaip Btk aktyvumo inhibitoriai |
| HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 14 | 289.00 EUR |
| 2026-11-02 |